Azurity Prescription drugs Proclaims the Availability of ARYNTA™ (lisdexamfetamine dimesylate) Oral Resolution, CII
Woburn, MA, April 06, 2026 (GLOBE NEWSWIRE) -- Azurity Prescription drugs, Inc.…
Rhythm Prescription drugs Pronounces FDA Approval of IMCIVREE® (setmelanotide) for Sufferers with Bought Hypothalamic Weight problems
-- First and best FDA-approved treatment for the remedy of obtained hypothalamic…
